Variant report

Variant	rs144909160
Chromosome Location	chr19:18888027-18888028
allele	G/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr19:18873859..18875560-chr19:18886840..18888488,3	K562	blood:
2	chr19:18836550..18839278-chr19:18885925..18888717,2	K562	blood:
3	chr19:18858094..18859912-chr19:18886098..18888648,2	K562	blood:
4	chr19:18875448..18876988-chr19:18887590..18889948,2	MCF-7	breast:
5	chr19:18885317..18890245-chr19:18892616..18897433,6	MCF-7	breast:

Extended variants
information (count: 7 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv911282	chr19:18624964-18928480	ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	60 gene(s)	inside rSNPs	diseases
2	nsv911293	chr19:18872917-19050957	Flanking Active TSS Genic enhancers Strong transcription Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	40 gene(s)	inside rSNPs	diseases
3	nsv911294	chr19:18872917-19093619	Active TSS Weak transcription Strong transcription Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	43 gene(s)	inside rSNPs	diseases
4	nsv911295	chr19:18874483-18902592	Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Strong transcription Bivalent/Poised TSS Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
5	nsv911296	chr19:18874483-18915988	Flanking Active TSS Enhancers Strong transcription Bivalent Enhancer Active TSS Genic enhancers Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
6	nsv833777	chr19:18875936-19031076	Weak transcription ZNF genes & repeats Genic enhancers Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	38 gene(s)	inside rSNPs	diseases
7	esv3423006	chr19:18886977-18889825	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Genic enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:18854600-18895800	Weak transcription	Right Atrium	heart
2	chr19:18862600-18888400	Weak transcription	Aorta	Aorta
3	chr19:18865600-18894600	Weak transcription	Primary T helper cells PMA-I stimulated	--
4	chr19:18865600-18896000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
5	chr19:18868200-18890600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
6	chr19:18873800-18889200	Weak transcription	Duodenum Smooth Muscle	Duodenum
7	chr19:18873800-18889200	Weak transcription	Left Ventricle	heart
8	chr19:18873800-18895600	Weak transcription	Ovary	ovary
9	chr19:18873800-18896200	Weak transcription	Brain Angular Gyrus	brain
10	chr19:18875200-18889200	Weak transcription	Adipose Nuclei	Adipose
11	chr19:18876200-18888800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr19:18876400-18888600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr19:18880600-18888400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
14	chr19:18880600-18889400	Weak transcription	Skeletal Muscle Female	skeletal muscle
15	chr19:18880600-18895800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
16	chr19:18880800-18892600	Weak transcription	Primary B cells from peripheral blood	blood
17	chr19:18882000-18890600	Weak transcription	Brain Anterior Caudate	brain
18	chr19:18883000-18889600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
19	chr19:18883200-18888600	Weak transcription	Brain Inferior Temporal Lobe	brain
20	chr19:18883400-18889200	Weak transcription	Primary T helper cells fromperipheralblood	blood
21	chr19:18884200-18893000	Weak transcription	Esophagus	oesophagus
22	chr19:18886000-18888400	Weak transcription	Right Ventricle	heart
23	chr19:18886000-18888600	Strong transcription	Breast Myoepithelial Primary Cells	Breast
24	chr19:18886400-18889600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr19:18886600-18888200	Enhancers	NHDF-Ad	bronchial
26	chr19:18886600-18888600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
27	chr19:18886800-18888200	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
28	chr19:18886800-18888400	Bivalent Enhancer	Fetal Muscle Leg	muscle
29	chr19:18886800-18888800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr19:18887000-18888400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr19:18887200-18888800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
32	chr19:18887400-18888200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr19:18887400-18892600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
34	chr19:18887400-18895600	Weak transcription	Lung	lung
35	chr19:18887600-18888200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
36	chr19:18887600-18888600	Weak transcription	Brain Hippocampus Middle	brain
37	chr19:18887600-18889000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
38	chr19:18887600-18894000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr19:18887600-18899200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
40	chr19:18887800-18888600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
41	chr19:18887800-18888800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr19:18887800-18893000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
43	chr19:18887800-18893000	Weak transcription	HSMMtube	muscle
44	chr19:18887800-18895800	Weak transcription	Pancreas	Pancrea
45	chr19:18888000-18888200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
46	chr19:18888000-18888200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr19:18888000-18888200	Enhancers	Gastric	stomach
48	chr19:18888000-18888200	Bivalent Enhancer	NH-A	brain
49	chr19:18888000-18888400	Weak transcription	Stomach Smooth Muscle	stomach
50	chr19:18888000-18888600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links